Skip to main content

Treatment of hemangiomas of infancy

Buy Article:

$43.00 plus tax (Refund Policy)


Hemangiomas of infancy are the most common tumors of childhood. They are clinically heterogeneous and as such require individualized treatment plans. Although there are no Food and Drug Administration (FDA)-approved agents for treatment of hemangiomas of infancy, there are many widely used therapeutic options available. This review highlights the treatments currently in use and the factors that direct treatment.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: hemangioma; management; therapy; treatment

Document Type: Research Article

Affiliations: Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI

Publication date: 2005-03-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more